ACR Convergence 2024

November 14-19, 2024. Washington, DC.

View by Number View by Title View Sessions

Sunday, November 17, 2024

10:30AM-12:30PM: Abstract Number: 1597

Baseline Glucocorticoid-Related Toxicity in Newly-Diagnosed and Relapsing ANCA-Associated Vasculitis

Vasculitis – ANCA-Associated Poster II

10:30AM-12:30PM: Abstract Number: 1554

Belimumab Increases SLE Responder Index-4 Response Rates versus Placebo in Early Active Systemic Lupus Erythematosus: A Large Integrated Analysis of Belimumab Trials

SLE – Treatment Poster II

10:30AM-12:30PM: Abstract Number: 1530

Belimumab-Treated Patients with Systemic Lupus Erythematosus Without Prior Immunosuppressant Use Have More Favorable Clinical Outcomes Than Those with Prior Use of an Immunosuppressant

SLE – Diagnosis, Manifestations, & Outcomes Poster II

10:30AM-12:30PM: Abstract Number: 1074

Bending the Curve on Inbox Bloat: A Patient Portal Project to Mature-the-Message via Nurse Triage to Reduce Provider Inbox Time

Measures & Measurement of Healthcare Quality Poster

10:30AM-12:30PM: Abstract Number: 1305

Bingo: A Winning Pediatric Rheumatology Teaching Strategy?

Professional Education Poster

10:30AM-12:30PM: Abstract Number: 1299

Board-Style Rheumatology Teaching for Medicine Residents: Novel Approach to Curriculum Development

Professional Education Poster

10:30AM-12:30PM: Abstract Number: 0882

Brepocitinib, a Selective TYK2/JAK1 Inhibitor Under Evaluation for the Treatment of Dermatomyositis, Reduces Inflammatory Cytokine Signaling and Interferon-induced Apoptosis in Primary Human Epidermal Keratinocytes

Cytokines & Cell Trafficking Poster

10:30AM-12:30PM: Abstract Number: 1058

Bridging the Care Gap Between Hospital Discharge and Outpatient Care Transition for Pediatric Rheumatology Patients: An RN-led Quality Improvement Project

Measures & Measurement of Healthcare Quality Poster

10:30AM-12:30PM: Abstract Number: 1309

Bridging the Gap: Evaluating Ophthalmology Training Amongst Pediatric Rheumatology Fellows

Professional Education Poster

10:30AM-12:30PM: Abstract Number: 1013

Burden of Emergency Department Visits and Their Outcomes Among Patients with Rheumatoid Arthritis: Insights from the Nationwide Emergency Department Sample (NEDS)

Healthcare Disparities in Rheumatology Poster II

10:30AM-12:30PM: Abstract Number: 1430

C57BL/6.NOD-Aec1Aec2 Mice Recapitulate Sjögren’s Serology Better Than NOD.B10Sn-H2b Models and JAK Inhibitor Treatment Improves Immunoglobulins and Salivary Gland Inflammation but Not Salivary Flow in Sjögren’s Mice

Sjögren's Syndrome – Basic & Clinical Science Poster I

10:30AM-12:30PM: Abstract Number: 1310

Cadaver Lab Improves Rheumatology Trainees’ Skills in Identifying Joint Anatomy and Performance of Joint Procedures

Professional Education Poster

10:30AM-12:30PM: Abstract Number: 1638

Calprotectin, a Mechanistically Informed Biomarker for Clinically Isolated Aortitis

Vasculitis – Non-ANCA-Associated & Related Disorders Poster II

10:30AM-12:30PM: Abstract Number: 1178

Can Immersive Virtual Reality Improve the Effect of Meditation for People with Fibromyalgia?

Orthopedics, Low Back Pain, & Rehabilitation – ACR/ARP Poster

10:30AM-12:30PM: Abstract Number: 1486

Cardiovascular Risk in Systemic Lupus Erythematosus: Carotid Ultrasonography Is Useful for the Re-stratification of Cardiovascular Risk Determined by Score2

SLE – Diagnosis, Manifestations, & Outcomes Poster II

«Previous Page
1
…
7
8
9
10
11
…
59
Next Page»

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].